Both the MMCC and the dispensaries will be unable to access the CRISP services or see any patient data because of this. As a covered entity, MMCC will be held accountable for adhering to all of the CRISP rules and procedures outlined in a data usage agreement. Approval The Clinical Advisory Board has given its stamp of approval to the Use Case Policy that has been outlined below.